{
    "SPADE_UN_22864": {
        "Sequence Information": {
            "Peptide Name": "Citropin 1.1 [G15P]-G, Citropin A",
            "Sequence": "GLFDVIKKVASVIGPLG",
            "Sequence Length": 17,
            "Biological Activity": [
                "Anticancer",
                "Anti-Mammalian Cell"
            ],
            "Binding Target": "1. Lipid Bilayer",
            "Source": "",
            "Gene": "",
            "PDB ID": "",
            "UniProt Entry": [
                {
                    "uniprotId": "P81835",
                    "uniprotUrl": "http://www.uniprot.org/uniprot/P81835",
                    "description": "The amino acid sequence of the current peptide coincides with the amino acid sequence of the UniProt entry."
                }
            ],
            "Literature": [
                {
                    "Title": "The design and anticancer activity of a citropin1.1 hybrid peptide with selective activity against highly invasive metastatic cell lines.",
                    "Pubmed ID": "",
                    "Reference": "Int J Res Pharm Sci. 2019;10:3544–3553",
                    "Author": "Almaaytah A, Alaraj M",
                    "URL": "http://www.ncbi.nlm.nih.gov/pubmed/"
                }
            ],
            "Mass": 1713.07,
            "PI": 8.59,
            "Net Charge": 1,
            "Hydrophobicity": 1.11,
            "Frequent Amino Acids": "GVI",
            "Absent Amino Acids": "CEHMNOQRTUWY",
            "Basic Residues": 2,
            "Acidic Residues": 1,
            "Hydrophobic Residues": 9,
            "Polar Residues": 8,
            "Positive Residues": 2,
            "Negative Residues": 1,
            "SPADE ID": "SPADE_UN_22864",
            "Similar Sequences": [
                {
                    "SPADE_ID": "SPADE_N_09447",
                    "Similarity": 1.0,
                    "Sequence": "GLFDVIKKVASVIG"
                },
                {
                    "SPADE_ID": "SPADE_N_09448",
                    "Similarity": 1.0,
                    "Sequence": "GLFDVIKKVASVI"
                },
                {
                    "SPADE_ID": "SPADE_N_09449",
                    "Similarity": 1.0,
                    "Sequence": "GLFDVIKKVASV"
                }
            ],
            "Hemolytic Activity": "Vero cells:IC50=68.9 µM,Human umbilical vein endothelial cells HUVEC:IC50=60.9 µM,Human erythrocytes:88.6% Hemolysis=90 µM,Human erythrocytes:66% Hemolysis=70 µM,Human erythrocytes:39.5% Hemolysis=50 µM,Human erythrocytes:17.8% Hemolysis=30 µM,Human erythrocytes:13.1% Hemolysis=20",
            "Target Organism": "Human prostate adenocarcinoma PC-3(IC50=42.4µM),Human prostate cancer DU145(IC50=46.7µM),Human prostate adenocarcinoma LNCaP(IC50=41.5µM),Human breast adenocarcinoma MCF-7(IC50=39.3µM)"
        }
    }
}